Advertisement
Research Article| Volume 11, ISSUE 3, P327-331, May 1991

Glomerular injury and proteolytic enzymes

  • William H. Baricos
    Correspondence
    Address reprint requests to William H. Baricos, PhD, Department of Biochemistry, Tulane Medical School, 1430 Tulane Ave, New Orleans, LA 70112.
    Footnotes
    Affiliations
    Department of Biochemistry, Tulane Medical School, New Orleans, LA, and the Department of Medicine, University of Arkansas for Medical Sciences, Little Rock, AK, USA
    Search for articles by this author
  • Sudhir V. Shah
    Affiliations
    Department of Biochemistry, Tulane Medical School, New Orleans, LA, and the Department of Medicine, University of Arkansas for Medical Sciences, Little Rock, AK, USA
    Search for articles by this author
  • Author Footnotes
    ∗ Drs Baricos and Shah are former Established Investigators of the American Heart Association and portions of the work cited from our laboratory was carried out during the tenure of these awards.
DOI:https://doi.org/10.5555/uri:pii:027092959190052L
Glomerular injury and proteolytic enzymes
Previous ArticleOxidant mechanisms in glomerulonephritis
Next ArticleArachidonic acid metabolites in glomerular immune injury
      This paper is only available as a PDF. To read, Please Download here.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Seminars in Nephrology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Register: Create an account
      Institutional Access: Sign in to ScienceDirect

      References

        • Cochrane C.G.
        • Unanue E.R.
        • Dixon F.J.
        A role of polymorphonuclear leukocytes and complement in nephrotoxic nephritis.
        J Exp Med. 1965; 122: 99-116
        • Cochrane C.G.
        • Aikin B.S.
        Polymorphonuclear leukocytes in immunological reactions.
        J Exp Med. 1966; 124: 733-752
        • Hawkins D.
        • Cochrane C.G.
        Glomerular basement membrane damage in immunologic glomerulonephritis.
        Immunology. 1968; 14: 665-681
        • Barrett A.J.
        Introduction to the history and classification of tissue proteinases.
        in: Barrett A.J. Protineases in Mammalian Cells and Tissues. North-Holland, Amsterdam, The Netherlands1977: 1-55

      5. Baricos WH, Shah SV: Editorial review: Proteolytic enzymes as mediators of glomerular injury. Kidney Int (accepted for publication)

        • Janoff A.
        • Zeligs J.D.
        Vascular injury and lysis of basement membrane in vitro by neutral protease of human leukocytes.
        Science. 1968; 161: 702-704
        • Davies M.
        • Coles G.A.
        • Hughes K.T.
        Glomerular basement membrane injury by neutrophil and monocyte neutral proteinases.
        Renal Physiol (Basel). 1980; 3: 106-111
        • Keiser H.
        • Greenwald R.A.
        • Feinstein G.
        • et al.
        Degradation of cartilage proteoglycan by human leukocyte granule neutral proteases—a model of joint injury.
        J Clin Invest. 1976; 57: 625-632
        • Janoff A.
        • Feinstein G.
        • Malemud C.J.
        • et al.
        Degradation of cartilage proteoglycan by human leukocyte granule neutral proteases—a mode of joint injury.
        J Clin Invest. 1976; 57: 615-624
        • McDonald J.A.
        • Kelley D.G.
        Degradation of fibronectin by human leukocyte elastase.
        J Biol Chem. 1980; 255: 8848-8858
        • Mainardi C.L.
        • Dixit S.
        • Kang A.H.
        Degradation of type IV (basement membrane) collagen by a proteinase isolated from human polymorphonuclear leukocyte granules.
        J Biol Chem. 1980; 255: 5435-5441
        • Pipoly D.J.
        • Crouch E.C.
        Degradation of native type IV procollagen by human neutrophil elastase. Implications for leukocyte-mediated degradation of basement membranes.
        Biochemistry. 1987; 26: 5748-5754
        • Vissers M.C.M.
        • Winterbourn C.C.
        • Hunt J.S.
        Degradation of glomerular basement membrane by human neutrophils in vitro.
        Biochim Biophys Acta. 1984; 804: 154-160
        • Vissers M.C.M.
        • Winterbourn C.C.
        Gelatinase contributes to the degradation of glomerular basement membrane collagen by human neutrophils.
        Collagen Rel Res. 1988; 8: 113-122
        • Vissers M.C.M.
        • Wiggins R.
        • Fantone J.C.
        Comparative ability of human monocyte and neutrophils to degrade glomerular basement membrane in vitro.
        Lab Invest. 1989; 60: 831-838
        • Vissers M.C.M.
        • Winterbourn C.C.
        Activation of human neutrophil gelatinase by endogenous serine proteinases.
        Biochem J. 1988; 249: 327-331
        • Murphy G.
        • Bretz U.
        • Baggiolini M.
        • et al.
        The latent collagenase and gelatinase of human polymorphonuclear neutrophil leucocytes.
        Biochem J. 1980; 192: 517-525
        • Okada Y.
        • Watanabe S.
        • Nakanishi I.
        • et al.
        Inactivation of tissue inhibitor of metalloproteinases by neutrophil elastase and other serine proteinases.
        FEBS Lett. 1988; 229: 157-160
        • Brower M.S.
        • Harpel P.C.
        Proteolytic cleavage and inactivation of alpha-2-plasmin inhibitor and Ci inactivator by human polymorphonuclear leukocyte elastase.
        J Biol Chem. 1982; 257: 9849-9854
        • Miller F.
        • Kuschner M.
        Alpha 1-antitrypsin deficiency, emphysema, necrotizing angiitis and glomerulonephritis.
        Am J Med. 1969; 46: 615-623
        • Moroz S.P.
        • Cutz E.
        • Balfe J.W.
        • et al.
        Membranoproliferative glomerulonephritis in childood cirrhosis associated with alpha 1-antitrypsin deficiency.
        Pediatrics. 1976; 57: 232-238
        • Rodriguez-Soriano J.
        • Fidalgo I.
        • Camarero C.
        • et al.
        Juvenile cirrhosis and membranous glomerulonephritis in a child with alpha 1-antitrypsin deficiency PiSZ.
        Acta Pediatr Scand. 1978; 67: 793-796
        • Lewis M.
        • Kallenbach J.
        • Zaltzman M.
        • et al.
        Severe deficiency of alpha-1-antitrypsin associated with cutaneous vasculitis, rapidly progressive glomerulonephritis, and colitis.
        Am J Med. 1985; 79: 489-494
        • Johnson R.J.
        • Couser W.G.
        • Alpers C.E.
        • et al.
        The human neutrophil serine proteinases, elastase and cathepsin G, can mediate glomerular injury in vivo.
        J Exp Med. 1988; 168: 1169-1174
        • Schrijver G.
        • Schalkwijk J.
        • Robben J.C.M.
        • et al.
        Antiglomerular basement membrane nephritis in beige mice.
        J Exp Med. 1989; 169: 1435-1448
        • Hancock W.
        • Atkins R.
        Activation of coagulation pathways and fibrin deposition in human glomerulonephritis.
        Semin Nephrol. 1985; 5: 69-77
        • Mackay A.R.
        • Corbitt R.H.
        • Hartzler J.L.
        • et al.
        Basement membrane type IV collagen degradation: Evidence for the involvement of a proteolytic cascade independent of metalloproteinases.
        Cancer Res. 1990; 50: 5997-6001
        • Mochan E.
        • Keler T.
        Plasmin degradation of cartilage proteoglycan.
        Biochem Biophys Acta. 1984; 800: 312-315
        • Liotta L.A.
        • Goldfarb R.H.
        • Terranova V.P.
        Cleavage of laminin by thrombin and plasmin: Alpha thrombin selectively cleaves the beta chain of laminin.
        Throm Res. 1981; 21: 663-673
        • Liotta L.A.
        • Goldfarb R.H.
        • Brundage R.
        • et al.
        Effect of plasminogen activator (urokinase), plasmin, and thrombin on glycoprotein and collagenous components of basement membrane.
        Cancer Res. 1981; 41: 4629-4636
        • Jones P.A.
        • Werb Z.
        Degradation of connective tissue matrices by macrophages. II. Influence of matrix composition in proteolysis of glycoproteins, elastin, and collagen by macrophages in culture.
        J Exp Med. 1980; 152: 1527-1536
        • Shah S.V.
        Effect of thrombin on cyclic AMP content in glomeruli isolated from rat kidney.
        Kidney Int. 1989; 35: 824-829
        • Dousa T.P.
        • Shah S.V.
        • Abboud H.E.
        Potential role of cyclic nucleotides in glomerular pathophysiology.
        in: Advances in Cyclic Nucleotide Research. Vol 12. Raven, New York, NY1980: 285-298
        • Dworkin L.D.
        • Uchikawa I.
        • Brenner B.M.
        Hormonal modulation of glomerular function.
        Am J Physiol. 1983; 244: F95-F104
        • Jennette J.C.
        • Tidwell R.R.
        • Geratz J.D.
        • et al.
        Amelioration of immune complex-mediated glomerulonephritis by synthetic protease inhibitors.
        Am J Pathol. 1987; 127: 499-506
        • Ikehara S.
        • Shimamura K.
        • Aoyama T.
        • et al.
        Effect of FUT- 175, a new synthetic protease inhibitor, on the development of lupus nephritis in (NZB × NZW)F1 mice.
        Immunology. 1985; 55: 595-600
        • Hibbs M.S.
        • Hasty K.A.
        • Seyer J.M.
        • et al.
        Biochemical and immunological characterization of the secreted forms of human neutrophil gelatinase.
        J Biol Chem. 1985; 260: 2493-2500
        • Murphy G.
        • Ward R.
        • Hembry R.M.
        • et al.
        Characterization of gelatinase from pig polymorphonuclear leukocytes. A metalloproteinase resembling tumor type IV collagenase.
        Biochem J. 1989; 258: 463-472
        • Lovett D.H.
        • Sterzel R.B.
        • Kashgarian M.
        • et al.
        Neutral proteinase activity produced in vitro by cells of the glomerular mesangium.
        Kidney Int. 1983; 23: 342-439
        • Davies M.
        • Thomas G.J.
        • Martin J.
        • et al.
        The purification and characterization of a glomerular-basement-membrane-degrading neutral proteinase from rat mesangial cells.
        Biochem J. 1988; 251: 419-425
        • Martin J.
        • Davies M.
        • Thomas G.
        • et al.
        Human mesangial cells secrete a GBM-degrading neutral proteinase and a specific inhibitor.
        Kidney Int. 1989; 36: 790-801
        • Yurchenco P.D.
        • Schittny J.C.
        Molecular architecture of basement membranes.
        FASEB J. 1990; 4: 1577-1590
        • Baricos W.H.
        • Murphy G.
        • Zhou Y.
        • et al.
        Degradation of glomerular basement membrane by purified mammalian metalloproteinases.
        Biochem J. 1988; 254: 609-612
        • Shah S.V.
        • Baricos W.H.
        • Basci A.
        Degradation of glomerular basement membrane by stimulated neutrophils.
        J Clin Invest. 1987; 79: 25-31
        • Nguyen H.H.
        • Baricos W.H.
        • Shah S.V.
        Degradation of glomerular basement membrane by a neutral metalloproteinase(s) present in glomeruli isolated from normal rat kidney.
        Biochem Biophys Res p. 1986; 141: 898
        • Le Q.C.
        • Shah S.V.
        • Nguyen H.H.
        • et al.
        A novel metalloproteinase present in freshly isolated rat glomeruli.
        Am J Physiol. April 1991; (in press)
        • Le Q.
        • Cortez S.
        • Hguyen H.
        • et al.
        Glomerular neutral metalloproteinase: Characterization and activity in animal models of human glomerular disease.
        in: Proceedings of the Matrix Metalloproteinase Conference. September 11–15, 1989 (in press)
        • Baricos W.H.
        • Cortez S.L.
        • Le Q.C.
        • et al.
        Glomerular basement membrane degradation by endogenous cysteine proteinases present in isolated rat glomeruli.
        Kidney Int. 1990; 38: 395-401
        • Baricos W.H.
        • Shah S.V.
        Role of cathepsin B and L in anti-glomerular basement membrane nephritis in rats.
        Renal Physiol Biochem. 1989; 12: 400-405
        • Yokota S.
        • Tsuji H.
        • Kato K.
        Immunocytochernical localization of cathepsin B in rat kidney. I. Light microscopic study using the indirect immunoenzyme technique.
        J Histochem Cytochem. 1986; 34: 891-897
        • Baricos W.H.
        • Zhou Y.
        • Mason R.W.
        • et al.
        Human kidney cathepsins B and L. Characterization and potential role in degradation of glomerular basement membrane.
        Biochem J. 1988; 252: 301-304
        • Thomas G.J.
        • Davies M.
        The potential role of human kidney cortex cysteine proteinases in glomerular basement membrane degradation.
        Biochem Biophyisca Acta. 1989; 990: 246-253
        • Baricos W.H.
        • O'Connor S.E.
        • Cortez S.L.
        • et al.
        The cyseine proteinase inhibitor, E-64, reduces proteinuria in an experimental model of glomerulonephritis.
        Biochem Biophys Res Comm. 1988; 155: 1318-1323
        • Baricos W.H
        • Cortez S.L.
        • Dicarlo R.M.
        • et al.
        Evidence suggesting a role for cathepsin L in anti-GBM antibody disease.
        Kidney Int. 1990; 37 (abstr): 407
        • Hanada K.
        • Tamai M.
        • Adachi T.
        • et al.
        Characterization of the new analogs of E-64 and their therapeutic application.
        in: Katunuma N. Umezawa H. Holzer H. Proteinase Inhibitors: Medical and Biological Aspects. Scientific Society Press, Tokyo, Japan1983: 25-36
        • Kirschke H.
        • Wikstrom P.
        • Shaw E.
        Active center differences between cathepsins L and B: The S1 binding region.
        FEBS Lett. 1988; 228: 128-130

      Article info

      Footnotes

      ☆Work cited from the authors' laboratories was sponsored by grants from the American Heart Association (National Center and Louisiana Affiliate), the Research Service of the Veterans Administration Hospital, and NIH grant R01-DK41480.

      Identification

      DOI: https://doi.org/10.5555/uri:pii:027092959190052L

      Copyright

      © 1991 Published by Elsevier Inc.

      ScienceDirect

      Access this article on ScienceDirect

      The content on this site is intended for healthcare professionals.


      We use cookies to help provide and enhance our service and tailor content. To update your cookie settings, please visit the Cookie Preference Center for this site.
      Copyright © 2023 Elsevier Inc. except certain content provided by third parties.


      RELX